Earnings, Revenue Beat the Street
Monsanto reported first-quarter earnings of $0.62 a share, crushing the $0.37 expected by analysts. Revenue of $2.94 billion also beat the $2.64 billion consensus number and management raised full-year guidance. MON is up 4 percent before the bell on my tradeMONSTER platform.
Anatabine Data Lifts Star Scientific
Star Scientific reported preliminary results from a three-month study of its anatabine compound, indicating that the substance can help patients with autoimmune thyroiditis. The full report is still being completed for peer review, but the buyers are jumping in now, and STSI is up 13 percent in early trading.
Yum Falls on Weak China Sales
Yum! Brands reported that fourth-quarter sales shrank by 6 percent, compared with its earlier forecast for a 4 percent decline. The news follows bad publicity from a news report about the company's food safety. YUM is down 4 percent in the premarket.
Perion Network Reports Fast Growth
Perion Network said that fourth-quarter revenue more than doubled to $21 million. It's also forecasting 80 percent growth in 2013. While the company isn't followed by analysts, that's still pretty good news and PERI is up 18 percent before the bell.
More From optionMONSTER